{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Morton Grove",
      "state": "IL",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "72876",
      "recalling_firm": "Morton Grove Pharmaceuticals, Inc.",
      "address_1": "6451 Main St",
      "address_2": "N/A",
      "postal_code": "60053-2633",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "recall_number": "D-0571-2016",
      "product_description": "Lindane Lotion, USP 1%, For External use Only, Rx Only, 2 fl oz (60 mL) bottle, MGP, NDC 60432-833-60",
      "product_quantity": "39,187 bottles",
      "reason_for_recall": "Super-Potent Drug: Out of Specification Assay test results were reported for stability samples.",
      "recall_initiation_date": "20151215",
      "center_classification_date": "20160115",
      "termination_date": "20160913",
      "report_date": "20160127",
      "code_info": "Lot #: UP1103, Exp 04/2016; UQ1001, Exp 04/2017",
      "more_code_info": ""
    }
  ]
}